Literature DB >> 3071417

Malignant pleural mesothelioma treatment: the current state of the art.

G Falkson1, A S Alberts, H C Falkson.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 3071417     DOI： 10.1016/0305-7372(88)90023-0

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  5 in total

Review 1.  Chemotherapy in malignant mesothelioma: a review.

Authors:  A Krarup-Hansen; H H Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

2.  Targeting mesothelioma using an infectivity enhanced survivin-conditionally replicative adenoviruses.

Authors:  Zeng B Zhu; Sharmila K Makhija; Baogen Lu; Minghui Wang; Shuyi Wang; Koichi Takayama; Gene P Siegal; Paul N Reynolds; David T Curiel
Journal:  J Thorac Oncol       Date:  2006-09       Impact factor: 15.609

3.  Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients.

Authors:  D J Sugarbaker; J P Garcia; W G Richards; D H Harpole; E Healy-Baldini; M M DeCamp; S J Mentzer; M J Liptay; G M Strauss; S J Swanson
Journal:  Ann Surg       Date:  1996-09       Impact factor: 12.969

4.  An extended phase II trial of ifosfamide plus mesna in malignant mesothelioma.

Authors:  G Falkson; M Hunt; E C Borden; J A Hayes; C I Falkson; T J Smith
Journal:  Invest New Drugs       Date:  1992-11       Impact factor: 3.850

5.  High-dose methotrexate in the treatment of malignant mesothelioma of the pleura. A phase II study.

Authors:  O P Solheim; G Saeter; A M Finnanger; A E Stenwig
Journal:  Br J Cancer       Date:  1992-06       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.